Crucell Getting STAR Technology Through ChromaGenics Purchase March 17, 2004 By Cormac Sheridan No Comments
BioTie Gains Ground On News Of Bioheparin Deal With Aventis March 10, 2004 By Cormac Sheridan No Comments
Basilea Moving Infection Drug Into Phase III, Launching IPO March 10, 2004 By Cormac Sheridan No Comments
BioTie Gains Ground On News Of Bioheparin Deal With Aventis March 10, 2004 By Cormac Sheridan No Comments
Basilea Moving Infection Drug Into Phase III, Launching IPO March 10, 2004 By Cormac Sheridan No Comments
Active Biotech Cuts Work Force; Focus Now On Current Portfolio March 3, 2004 By Cormac Sheridan No Comments
Active Biotech Cuts Work Force; Focus Now On Current Portfolio March 3, 2004 By Cormac Sheridan No Comments
Borean Pharma Brings In ApoA-I Project Via Proteopharma Buyout Feb. 25, 2004 By Cormac Sheridan No Comments
